Visual dysfunction, neurodegenerative diseases, and aging

Neurologic Clinics

Volumn 21, Issue 3, 2003, Pages 709-728

  Jackson, Gregory R ^a   Owsley, Cynthia ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; CATARACT; COLOR BLINDNESS; COLOR DISCRIMINATION; CONTRAST SENSITIVITY; DEGENERATIVE DISEASE; DIABETIC RETINOPATHY; DOPAMINERGIC NERVE CELL; EVOKED VISUAL RESPONSE; GLAUCOMA; HUMAN; LEARNING; MOVEMENT PERCEPTION; NERVE TRACT; NEUROFIBRILLARY TANGLE; NORTH AMERICA; OPTIC NERVE DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; READING; RETINA GANGLION CELL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD; VISUAL MEMORY;

EID: 0038578086     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(02)00107-X     Document Type: Review

References (194)

1. Sekuler R, Kline D, Dismukes K. Aging and human visual function. New York: Alan R. Liss; 1982.
2. Owsley C, Sloane ME. Vision and aging, In: Boller F, Grafman J, editors. Handbook of neuropsychology, vol. 4. Amsterdam: Elsevier; 1990. p. 229-49.
3. Weale RA. The senescence of human vision. New York: Oxford University Press; 1992.
4. Kline DW, Schieber F. Vision and aging. In: Birren JE, Schaie KW, editors. Handbook of the psychology of aging. New York: Van Nostrand Reinhold; 1985. p. 296-331.
5. Schieber F, Baldwin CL. Vision, audition, and aging research. In: Blanchard-Fields F, Hess TM, editors. Perspectives on cognitive change in adulthood and aging. New York: McGraw-Hill; 1996. p. 122-62.
6. Hunt LA, Sadun AA, Bassi CJ. Review of the visual system in Parkinson's disease. Optom Vis Sci 1995;72:92-9.
7. Cronin-Golomb A. Vision in Alzheimer's disease. Gerontologist 1995;35:370-6.
8. Katz B, Rimmer S. Ophthalmologic manifestations of Alzheimer's disease. Surv Ophthalmol 1989;34:31-43.
9. Bodis-Wollner I, Tagliati M, Peppe A, et al. Visual and visual perceptual disorders in neurodegenerative diseases. Baillieres Clin Neurol 1993;2:461-91.
10. Sadun AA, Bassi CJ. The visual system in Alzheimer's disease. In: Cohen B, Bodis-Wollner I, editors. Vision and the brain. New York: Raven Press; 1990.
11. Sekuler R, Sekuler A. Visual perception and cognition. In: Evans JG, Williams TF, editors. The Oxford textbook of geriatric medicine. New York: Oxford University Press; 1992. p. 1-18.
12. National Advisory Eye Council. Vision research-a national plan: 1999-2003. Bethesda (MD): National Institutes of Health; 1999. p. 1-170.
13. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham eye study, I. Outline and major prevalence findings. Am J Epidemiol 1977;106:17-41.
14. Klein BEK, Klein R, Linton KLP. Prevalence of age-related lens opacities in a population: the Beaver Dam Eye Study. Ophthalmology 1992;99:546-52.
15. Rubin GS, Adamsons IA, Stark WJ. Comparison of acuity, contrast sensitivity, and disability glare before and after cataract surgery. Arch Ophthalmol 1993;111:56-61.
16. Elliott DB, Gilchrist J, Whitaker D. Contrast sensitivity and glare sensitivity changes with three types of cataract morphology: are these techniques necessary in a clinical evaluation of cataract? Ophthalmic Physiol Opt 1989;9:25-30.
17. Cataract Management Guideline Panel. Cataract in adults: management of functional impairment. Clinic practice guideline. Rockville (MD): Agency for Health Care Policy and Research, U.S. Department of Health and Human Services; 1993.
18. Mangione CM, Phillips RS, Lawrence MG, et al. Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol 1994;112:1419-25.
19. Steinberg EP, Tielsch JM, Schein OD, et al. National study of cataract surgery outcomes: variation in 4-month postoperative outcomes as reflected in multiple outcome measures. Ophthalmology 1994;101:1131-41.
20. Klein R, Wang Q, Klein BEK, et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-91.
21. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: the Beaver Dam eye study. Ophthalmology 1992;99:933-43.
22. Jackson GR, Owsley C, Curcio CA. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy. Ageing Research Reviews 2002;1:381-6.
23. Bressler NM, Bressler SB. Photodynamic therapy with verteprofin (Visudyne): impact on ophthalmology and visual science. Invest Ophthalmol Vis Sci 2000;41:624-8.
24. Age-related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 2001;119:1417-36.
25. Steinmetz RL, Haimovici R, Jubb C, et al. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol 1993;77:549-54.
26. Owsley C, Jackson GR, Cideciyan AV, et al. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci 2000;41:267-73.
27. Owsley C, Jackson GR, White MF, et al. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology 2001;108:1196-202.
28. Applegate RA, Adams AJ, Cavender JC, et al. Early color vision changes in age-related maculopathy. Applied Optics 1987;26:1458-62.
29. Mayer MJ, Ward B, Klein R, et al. Flicker sensitivity and fundus appearance in pre-exudative age-related maculopathy. Invest Ophthalmol Vis Sci 1994;35:1138-49.
30. Owsley C, Sloane ME, Skalka HW, et al. A comparison of the Regan Low-Contrast Letter Charts and contrast sensitivity testing in older patients. Clin Vis Scie 1990;5:325-34.
31. Sjostrand J, Frisen L. Contrast sensitivity in macular disease: a preliminary report. Acta Ophthalmol (Copenh) 1977;55:507-14.
32. Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute visual function questionnaire (NEI-VFQ). Arch Ophthalmol 1998;116:1496-504.
33. Mangione CM, Gutierrez PR, Lowe G, et al. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol 1999;128:45-53.
34. Williams RA, Brody BL, Thomas RG, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol 1998;116:514-20.
35. Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology 2002;109:1235-42.
36. Klaver CCW, Ott A, Hofman A, et al. Is age-related maculopathy associated with Alzheimer's disease? The Rotterdam Study. Am J Epidemiol 1999;150:963-8.
37. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 2000;80:389-93.
38. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. JAMA 1991;266:369-74.
39. Johnson CA. Psychophysical measurement of glaucomatous damage. Surv Ophthalmol 2001;45:S313-8.
40. Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 1997;115:777-84.
41. Turano KA, Rubin GS, Quigley HA. Mobility performance in glaucoma. Invest Ophthalmol Vis Sci 1999;40:2803-9.
42. Wilensky JT. The role of medical therapy in the rank order of glaucoma treatment. Curr Opin Ophthalmol 1999;10:109-11.
43. Yoles E, Schwartz M. Potential neuroprotective therapy for glaucomatous optic neuropathy. Surv Ophthalmol 1998;42:367-72.
44. National Society to Prevent Blindness. Vision problems in the U.S. data analysis, definitions, data sources, detailed data tables, analyses, interpretation. New York: National Society to Prevent Blindness; 1980.
45. Klein R, Klein BEK. Vision disorders in diabetes. In: Harris M, editor. Diabetes in America. Washington, DC: US Government Printing Office; 1995. NIH publication no. 95-1468. p. 1-45.
46. The DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes. The Diabetes Control and Complication Trial. N Engl J Med 1993;329:977-86.
47. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology 1991;98:766-85.
48. Bresnick GH, Condit RS, Palta M, et al. Association of hue discrimination loss and diabetic retinopathy. Arch Ophthalmol 1985;103:1317-24,
49. Greenstein VC, Chen H, Hood DC, et al. Retinal function in diabetic macular edema after focal laser photocoagulation. Invest Ophthalmol Vis Sci 2000;41:3655-64.
50. Pearson AR, Tanner V, Keightley SJ, et al. What effect does laser photocoagulation have on driving visual fields in diabetics? Eye 1998;12:64-8.
51. Russell PW, Sekuler R, Fetkenhour C. Visual functioning after pan-retinal photocoagulation: a survey. Diabetes Care 1985;8:57-60.
52. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 2001;119:1050-8.
53. Pitts DG. The effects of aging on selected visual functions: dark adaptation, visual acuity, stereopsis, and brightness contrast. In: Sekuler R, Kline D, Dismukes K, editors. Aging and human visual function. New York: Alan R. Liss; 1982. p. 131-59.
54. Weale RA. Senile changes in vision acuity. Trans Ophthalmol Soc UK 1975;95:36-8.
55. Weale RA. Senescent vision: is it all the fault of the lens? Eye 1987;1:217-21.
56. Bodis-Wollner I, Camisa JM. Contrast sensitivity measurement in clinical diagnosis. In: Lessell S, van Dalen JTW, editors. Neuro-ophthalmology, vol. 1. Amsterdam: Excerpta Medica; 1980. p. 373-401.
57. Owsley C, Sekuler R, Siemsen D. Contrast sensitivity throughout adulthood. Vision Res 1983;23:689-99.
58. Higgins KE, Jaffe MJ, Coletta NJ, et al. Spatial contrast sensitivity: importance of controlling the patient's visibility criterion. Arch Ophthalmol 1984;102:1035-41.
59. Burton KB, Owsley C, Sloane ME. Aging and neural contrast sensitivity: photopic vision. Vision Res 1993;33:939-46.
60. Sloane ME, Owsley C, Alvarez SL. Aging, senile miosis and spatial contrast sensitivity at low luminance. Vision Res 1988;28:1235-46.
61. Sloane ME, Owsley C, Jackson CA. Aging and luminance-adaptation effects in spatial contrast sensitivity. J Opt Soc Am [A] 1988;5:2181-90.
62. Schefrin BE, Tregear SJ, Harvey LO Jr, et al. Senescent changes in scotopic contrast sensitivity. Vision Res 1999;39:3728-36.
63. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci 1988;2:187-99.
64. Ginsburg AP. A new contrast sensitivity vision test chart. American Journal of Optometry and Physiological Optics 1984;61:403-7.
65. Haegerstrom-Portnoy G, Brabyn J, Schneck ME, Jumpolsky A. The SKILL card: an acuity test of reduced luminance and contrast. Invest Ophthalmol Vis Sci 1997;38:207-18.
66. Elliott DB, Bullimore MA. Assessing the reliability, discriminative ability, and validity of disability glare tests. Invest Ophthalmol Vis Sci 1993;34:108-19.
67. Wolf E. Glare and age. Arch Ophthalmol 1960;64:502-14.
68. Haegerstrom-Portnoy G, Schneck ME, Brabyn JA. Seeing into old age: vision function beyond acuity. Optom Vis Sci 1999;76:141-58.
69. Rubin GS, West SK, Munoz B, et al. A comprehensive assessment of visual impairment in a population of older Americans. Invest Ophthalmol Vis Sci 1997;38:557-68.
70. Verriest G. Further studies on acquired deficiency of color discrimination. J Opt Soc Am 1963;53:185-95.
71. Knoblauch K, Saunders F, Kusuda M, et al. Age and illuminance effects in the Farnsworth-Munsell 100-hue test. Applied Optics 1987;26:1441-8.
72. Lakowski R. Age and color vision. Adv Sci 1958;15:231-6.
73. Ohta Y, Kato H. Colour perception changes with age. Mod Probl Ophthalmol 1976;17:345-52.
74. Eisner A, Fleming SA, Klein ML, et al. Sensitivities in older eyes with good acuity: cross-sectional norms. Invest Ophthalmol Vis Sci 1987;28:1824-31.
75. Haegerstrom-Portnoy G, Hewlett SE, Barr SAN. S-cone loss with aging. In: Verriest G, editor. Colour vision deficiencies IX. The Hague; Junk Publisher; 1988. p. 349-56.
76. Johnson CA, Adams AJ, Twelker JC, et al. Age-related changes of the central visual field for short-wavelength sensitive pathways. J Opt Soc Am [A] 1988;5:2131-9.
77. Knoblauch K, Vital-Durand F, Barbur JL. Variation of chromatic sensitivity across the life span. Vision Res 2001;41:23-36.
78. Drance SM, Berry V, Hughes A. Studies of the effects of age on the central and peripheral isopters of the visual field in normal subjects. Am J Ophthalmol 1967;63:1667-72.
79. Wolf E. Studies on the shrinkage of the visual field with age. Highway Research Record 1967;167:1-7.
80. Brenton RS, Phelps CD. The normal visual field on the Humphrey field analyzer. Ophthalmologica 1986;193:56-74.
81. Haas A, Flammer J, Schneider U. Influence of age on the visual fields of normal subjects. Am J Ophthalmol 1986;101:199-203.
82. Johnson CA, Adams AJ, Lewis RA. Evidence for a neural basis of age-related visual field loss in normal observers. Invest Ophthalmol Vis Sci 1989;30:2056-64.
83. Misiak H. Age and sex differences in critical flicker frequency. J Exp Psychol 1947;37:318-32.
84. Coppinger NW. The relationship between critical flicker frequency and chronological age for varying levels of stimulus brightness. J Gerontol 1955;10:48-52.
85. Kelly DH, Flicker. In: Jameson D, Hurvich LM, editors. Handbook of sensory physiology. New York: Springer-Verlag; 1972. p. 273-302.
86. Wright CE, Drasdo N. The influence of age on the spatial and temporal contrast sensitivity function. Doc Ophthalmol 1985;59:385-95.
87. Mayer MJ, Kim CBY, Svingos A, et al. Foveal flicker sensitivity in healthy aging eyes. I. Compensating for pupil variation. J Opt Soc Am 1988;5:2201-9.
88. Ball K, Sekuler R. Improving visual perception in older observers. J Gerontol 1986;41:176-82.
89. Sekuler R, Hutman LP, Owsley C. Human aging and spatial vision. Science 1980;209:1255-6.
90. Wojciechowski R, Trick GL, Steinman SB. Topography of the age-related decline in motion sensitivity. Optom Vis Sci 1995;72:67-74.
91. Gilmore GC, Wenk HE, Naylor LA, et al. Motion perception and aging. Psychol Aging 1992;7:654-60.
92. Curcio CA, Millican CL, Allen KA, et al. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci 1993;34:3278-96.
93. Jackson GR, Owsley C. Scotopic sensitivity during adulthood. Vision Res 2000;40:2467-73.
94. Jackson GR, Owsley C, McGwin G. Aging and dark adaptation. Vision Res 1999;39:3975-82.
95. Kosnik W, Winslow L, Kline D, et al. Visual changes in daily life throughout adulthood. J Gerontol Psychol Scis 1988;43:P63-70.
96. Salthouse TA. Speed mediation of adult age differences in cognition. Dev Psychol 1993;29:722-38.
97. Ball KK, Roenker DL, Bruni JR. Developmental changes in attention and visual search throughout adulthood. In: Enns JT, editor. The development of attention: research and theory. North-Holland: Elsevier Science Publishers B.V.; 1990. p. 489-507.
98. Rabbitt PMA. An age-decrement in the ability to ignore irrelevant formation. J Gerontol 1965;20:233-8.
99. Plude DJ, Hoyer WJ. Age and the selectivity of visual information processing. Psychol Aging 1986;1:4-10.
100. Ball K, Beard BL, Roenker DL, et al. Age and visual search: expanding the useful field of view. J Opt Soc Am [A] 1988;5:2210-9.
101. Ball K, Owsley C, Sloane ME, et al. Visual attention problems as a predictor of vehicle crashes in older drivers. Invest Ophthalmol Vis Sci 1993;34:3110-23.
102. Owsley C, Ball K, McGwin G Jr, et al. Visual processing impairment and risk of motor vehicle crash among older adults. JAMA 1998;279:1083-8.
103. Owsley C, McGwin G Jr, Ball K. Vision impairment, eye disease, and injurious motor vehicle crashes in the elderly. Ophthalmic Epidemiol 1998;5:101-13.
104. Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 1990;31:2473-5.
105. Papadopoulos GC, Parnavelas JG. Distribution and synaptic organisation of dopaminergic axons in the lateral geniculate nucleus of the rat. J Comp Neurol 1990;294:356-61.
106. Reader TA, Quesney LF. Dopamine in the visual cortex of the cat. Experimentia 1986;42:1242-4.
107. Parkinson D. Evidence for a dopaminergic innervation of cat primary visual cortex. Neuroscience 1989;30:171-9.
108. Bodis-Wollner I, Yahr MD. Measurements of visual evoked potentials in Parkinson's disease. Brain 1976;101:661-71.
109. Gawel MJ, Das P, Vincent S, et al. Visual and auditory evoked responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1981;44:227-32.
110. Marx M, Bodis-Wollner I, Bobak P, et al. Temporal frequency-dependent VEP changes in Parkinson's disease. Vision Res 1986;26:185-93.
111. Bodis-Wollner I, Yahr MD, Mylin L, et al. Dopaminergic deficiency and delayed visual evoked potentials in humans. Ann Neurol 1982;11:478-83.
112. Iudice A, Virgili P, Muratorio A. The electroretinogram in Parkinson's disease. Research communications in psychology, Psychiatry and Behavior 1980;5:283-9.
113. Nightingale S, Mitchell KW, Howe JW. Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects. J Neurol Neurosurg Psychiatry 1986;49:1280-7.
114. Gottlob I, Scneider E, Heider W, et al. Alteration of visual evoked potentials and electroretinograms in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1987;66:349-57.
115. Jaffe MJ, Bruno G, Campbell G, et al. Ganzfeld electroretinographic findings in Parkinsonism: untreated patients and the effect of levodopa intravenous infusion. J Neurol Neurosurg Psychiatry 1987;50:847-52.
116. Ellis CJK, Allen TGL, Marsden CD, et al. Electroretinographic abnormalities in idiopathic Parkinson's disease and the effect of levodopa administration. Cin Vis Sci 1987;1:347-55.
117. Ellis CJK, Ikeda H. Evidence for retinal dopamine deficiency in Parkinson's disease. In: Bodis-Wollner I, Piccolino M, editors. Dopaminergic mechanism in vision. New York: Alan R. Liss; 1988. p. 239-51.
118. Murayama K, Adachi-Usami E, Yamada Y. Effects of L-Dopa on electroretinographic responses and pattern visual evoked potentials in juvenile Parkinsonism. Clin Vis Sci 1989;4:265-8.
119. Kupersmith MJ, Shakin E, Siegel IM, et al. Visual system abnormalities in patients with Parkinson's disease. Arch Neurol 1982;39:284-6.
120. Peppe A, Stanzione P, Pierelli F, et al. Low contrast stimuli chance PERG sensitivity to the visual dysfunction in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1992;82:453-7.
121. Stanzione P, Traversa R, Pierantozzi M, et al. An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease. Neurosci Lett 1992;140:125-8.
122. Langheinrich T, Tebartz van Elst L, Lagreze WA, et al. Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol 2000;111:66-74.
123. Regan D, Neima D. Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson's disease. Br J Ophthalmol 1984;68:885-9.
124. Bodis-Wollner I, Marx MS, Mitra S, et al. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 1987;110:1675-98.
125. Regan D, Maxner C. Orientation-selective visual loss in patients with Parkinson's disease. Brain 1987;110:415-32.
126. Bulens C, Meerwaldt JD, Van der Wildt GJ. Effect of stimulus orientation on contrast sensitivity in Parkinson's disease. Neurology 1988;38:76-81.
127. Robson JG. Spatial and temporal contrast-sensitivity functions of the visual system. J Opt Soc Am 1966;56:1141-2.
128. Kelly DH. Flickering patterns and lateral inhibition. J Opt Soc Am 1969;59:1361-70.
129. Price MJ, Feldman RG, Adelberg D, et al. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 1992;42:887-90.
130. Buttner T, Kuhn W, Patzold T, et al. L-dopa improves colour vision in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1994;7:13-9.
131. Buttner T, Kuhn W, Muller T, et al. Distorted color discrimination in 'de novo' parkinsonian patients. Neurology 1995;45:386-7.
132. Buttner T, Muller T, Kuhn W. Effects of apomorphine on visual functions in Parkinson's disease. J Neural Transm 2000;107:87-94.
133. Buttner T, Kuhn W, Muller T, et al, Color vision in Parkinson's disease: missing influence of amantadine sulphate. Clin Neuropharmacol 1995;18:458-63.
134. Regan BC, Freudenthaler N, Kolle R, et al. Colour discrimination thresholds in Parkinson's disease: results obtained with a rapid computer-controlled colour vision test. Vision Res 1998;38:3427-31.
135. Huang BA, Trenkwalder C, Arden GB, et al. Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease. Movement Disorders 1994:91-5.
136. Birch J, Kolle RU, Kunkel M, et al. Acquired colour deficiency in patients with Parkinson's disease. Vision Res 1998;38:3421-6.
137. Brun A, Gustafson L. Distribution of cerebral degeneration in Alzheimer's disease: a clinico-pathological study. Arch Psychiatr Nervenkr 1976;223:15-33.
138. Terry RD, Katzman R. Senile dementia of the Alzheimer type: defining a disease. In: Katzman R, Terry R, editors. The neurology of aging. Philadelphia: F. A. Davis; 1983. p. 51-83.
139. Lewis DA, Campbell MJ, Terry RD, et al. Laminar and regional distributions of neurofibrilary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 1987;7:1799-808.
140. Hinton DR, Sadun AA, Blanks JC, et al. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 1986;315:485-7.
141. Curcio CA, Drucker DN. Retinal ganglion cells in Alzheimer's disease and aging. Ann Neurol 1993;33:248-57.
142. Wright CE, Harding GFA, Orwin A. Presenile dementia: the use of the flash and pattern VEP in diagnosis. Electroencephalogr Clin Neurophysiol 1984;57:405-15.
143. Visser SI, Stam FC, Van Tilburg W, et al. Visual evoked response in senile and presenile ementia. Electroencephalogr Clin Neurophysiol 1976;40:385-92.
144. Orwin A, Wright CE, Harding GFA, et al. Serial visual evoked potential recordings in Alzheimer's disease. BMJ 1986;293:9-10.
145. Cosi V, Vitelli E, Gozzoli L, et al. Visual evoked potentials in aging of the brain. In: Courjon J, Mauguiere F, Revol M, editors. Clinical applications of evoked potentials in neurology. New York: Raven Press; 1982. p. 109-15.
146. Wright CE, Drasdo N, Harding GFA. Pathology of the optic nerve and visual association areas: information given by the flash and pattern visual evoked potential, and the temporal and spatial contrast sensitivity function. Brain 1987;110:107-20.
147. Wright CE, Harding GFA, Orwin A. The flash and pattern VEP as a diagnostic indicator of dementia. Doc Ophthalmol 1986;62:89-96.
148. Bajalan AAA, Wright CE, Vandervliet VJ. Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide-comparison with results in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1886;49:175-82.
149. Harding GFA, Wright CE, Orwin A. Primary presenile dementia: the use of the visual evoked potential as a diagnostic indicator. Br J Psychiatry 1985;147:532-9.
150. Visser SL, Van Tilburg W, Hooijer C, et al. Visual evoked potentials (VEPs) in senile dementia (Alzheimer's type) and in non-organic behavioral disorders in the elderly; comparison with EEG parameters. Electroencephalogr Clin Neurophysiol 1985;60:115-21.
151. Coben LA. The effect of aging and of dimming the stimulus upon the visual evoked response to reversing checks in man. Electroencephalogr Clin Neurophysiol 1977;43:559.
152. Katz B, Rimmer S, Iragui V, et al. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration. Ann Neurol 1989;26:221-5.
153. Trick GL, Barris MC, Bickler-Bluth M. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer's type. Ann Neurol 1989;26:226-31.
154. Schlotterer G, Moscovitch M, Crapper-McLaclan D. Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal ageing and Alzheimer's disease. Brain 1983;107:309-25.
155. Cronin-Golomb A, Corkin S, Rizzo JF, et al. Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol 1991;29:41-52.
156. Cronin-Golomb A, Rizzo JF, Corkin S, et al. Visual function in Alzheimer's disease and normal aging. Ann N Y Acad Sci 1991;640:23-35.
157. Cronin-Golomb A, Corkin S, Rosen TJ. Neuro-psychological assessment of dementia. In: Whitehouse PJ, editor. Dementia. Philadelphia: F. A. Davis; 1993. p. 130-64.
158. Cronin-Golomb A, Sugiura R, Corkin S, et al. Incomplete Achromatopsia in Alzheimer's Disease. Neurobiol Aging 1993;14:471-7.
159. Cronin-Golomb A, Corkin S, Growdon JH. Visual dysfunction predicts cognitive deficits in Alzheimer's Disease. Optom Vis Sci 1995;72:168-76.
160. Rizzo M, Nawrot M. Perception of movement and shape in Alzheimer's disease. Brain 1998;121:2259-70.
161. Duchek JM, Hunt L, Ball K, et al. Attention and driving performance in Alzheimer's Disease. J Gerontol Psychol Sci 1998;53B:P130-41.
162. Gilmore GC, Whitehouse PJ. Contrast sensitivity in Alzheimer's Disease: a 1-year longitudinal analysis. Optom Vis Sci 1995;72:83-91.
163. Gilmore GC, Levy JA. Spatial contrast sensitivity in Alzheimer's Disease: a comparison of two methods. Optom Vis Sci 1991;68:790-4.
164. Gilmore GC, Wenk HE, Naylor LA, et al. Motion perception and Alzheimer's Disease. J Gerontol Psychol Sci 1994;49:P52-7.
165. Nissen MJ, Corkin S, Buonanno FS, et al. Spatial vision in Alzheimer's disease. Arch Neurol 1985;42:667-71.
166. Kiyosawa M, Bosley TM, Chawluk J, et al. Alzheimer's disease with prominent visual symptoms. Ophthalmology 1989;96:1077-86.
167. Sadun AA. The optic neuropathy of Alzheimer's disease. Metab Pediatr Syst Ophthalmol 1989;12:64-8.
168. Sadun AA, Borchert M, DeVita E, et al. Assessment of visual impairments in Alzheimer's disease. Am J Ophthalmol 1987;104:113-20.
169. Mendola JD, Cronin-Golomb A, Corkin S, et al. Prevalence of visual deficits in Alzheimer's Disease. Optom Vis Sci 1995;72:155-67.
170. Mendez MF, Mendez MA, Martin R, et al. Complex visual disturbances in Alzheimer's disease. Neurology 1990;40:439-43.
171. Levine DN, Lee JM, Fisher CM. The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology 1993;43:305-13.
172. Gilmore GC, Wenk HE, Naylor LA, et al. Motion perception and Alzheimer's disease. J Gerontol Psychol Sci 1994;49:P52-7.
173. Allen PA, Namazi KH, Patterson MB, et al. Impact of adult age and Alzheimer's disease on levels of neural noise for letter matching. J Gerontol Psycholog Sci 1992;47:P344-9.
174. Gilmore GC, Thomas CW, Klitz T, et al. Contrast enhancement eliminates letter identification speed deficits in Alzheimer's disease. Invest Ophthalmol Vis Sci 1992;33:1-11.
175. Hof PR, Bouras C. Object recognition deficit in Alzheimer's disease: possible disconnection of the occipito-temporal component of the visual system. Neurosci Lett 1991;122:53-6.
176. Foldi NS, Jutagir R, Davidoff D, et al. Selective attention skills in Alzheimer's disease: performance on graded cancellation tests varying in density and complexity. J Gerontol Psychol Sci 1992;47:P146-53.
177. Baddeley AD, Bressi S, Sala SD, et al. The decline of working memory in Alzheimer's disease. Brain 1991;114:2521-42.
178. Hunt L, Morris JC, Edwards D, et al. Driving performance in persons with mild senile dementia of the Alzheimer type. J Am Geriatr Soc 1993;41:747-53.
179. Hof PR, Bouras C, Constantinidis J, et al. Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome. J Neuropathol Exp Neurol 1990;49:168-84.
180. Parasuraman R, Greenwood PM, Haxby JV, et al. Visuospatial attention in dementia of the Alzheimer type. Brain 1992;115:711-33.
181. Adelstein TB, Kesner RP, Strassberg DS. Spatial recognition and spatial order memory in patients with dementia of the Alzheimer's type. Neuropsychologia 1991;30:59-67.
182. Hof PR, Bouras C, Constantinidis J, et al. Balint's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway. Brain Res 1989;493:368-75.
183. Freedman M. Spatial and visual learning deficits in Alzheimer's and Parkinson's disease. Brain Cogn 1989;11:114-26.
184. Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol 1988;45:789-93.
185. Cogan DG. Visuospatial dysgnosia. Am J Ophthalmol 1978;88:361-8.
186. Cogan DG. Visual disturbances with focal progressive dementing disease. Am J Ophthalmol 1985;100:68-72.
187. Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer's disease. Ophthalmology 1990;97:9-17.
188. Rizzo JF III, Cronin-Golomb A, Growdon JH, et al. Retinocalcarine function in Alzheimer's disease: a clinical and electrophysiological study. Arch Neurol 1992;49:93-101.
189. Damasio AR. Disorders of complex visual processing: agnosias, achromatopsias, Balint's syndrome and related difficulties of orientation and construction. In: Mesulam MM, editor. Principles of behavioral neurology. Contemporary neurology series, vol. 26. Philadelphia: Davis, 1985. p. 259-88.
190. Scinto LFM, Daffner KR, Dressler D. A potential non-invasive neurobiological test for Alzheimer's disease. Science 1994;266:1051-4.
191. Caputo L, Casartelli M, Perrone C, et al. The 'eye test' in recognition of late-onset Alzheimer's disease. Arch Gerontol Geriatr 1998;27:171-7.
192. Litvan I, FitzGibbon EJ. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects? Neurology 1996;47:1324-6.
193. Loupe DN, Newman NJ, Green RC. Pupillary response to tropicamide in patients with Alzheimer's disease. Ophthalmology 1996;103:495-503.
194. Wright CE, Harding GFA, Orwin A. The flash and pattern VEP as a diagnostic indicator of dementia. Doc Ophthalmol 1986;62:89-96.